Cite
HARVARD Citation
Hoermann, G. et al. (2014). CD52 is a molecular target in advanced systemic mastocytosis. FASEB journal. 28 (8), pp. 3540-3551. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hoermann, G. et al. (2014). CD52 is a molecular target in advanced systemic mastocytosis. FASEB journal. 28 (8), pp. 3540-3551. [Online].